On November 20, 2023, in connection with the Dissolution, Evelo Biosciences, Inc. announced that Simba Gill ceased serving as the Company?s Chief Executive Officer, principal executive officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0505 USD | +26.25% | +6.54% | -17.89% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-17.89% | 959K | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- EVLO Stock
- News Evelo Biosciences, Inc.
- Evelo Biosciences, Inc. Announces Simba Gill Ceases as Chief Executive Officer